Search results for “Attention disorders” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 214 patents, we discovered top 52 key players by total patent application. Novartis AG, BIAL-Portela & Cia SA, Heptares Therapeutics Ltd. are dominant in this area. They take 51.87% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 70
BIAL-Portela & Cia SA
Porto, Portugal
Patent: 26
Heptares Therapeutics Ltd.
HERTFORD COUNTY, United Kingdom
Patent: 15
Novartis Pharma GmbH
Austria
Patent: 10
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 10
Bioprojet SCR
France
Patent: 7
Aventis Pharma SARL
France
Patent: 6
H. Lundbeck A/S
Hovedstaden, Denmark
Patent: 5
DAE HWA PHARM Co., Ltd.
South Korea
Patent: 5
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 4
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 43 patents applied in the last 5 years. We discover 15 most active companies in this area. The fast-growing Heptares Therapeutics Ltd., AstraZeneca Pharmaceutical Co., Ltd., Neurim Pharmaceuticals Ltd. take 58.14% of patent filing during this period.
Heptares Therapeutics Ltd.
HERTFORD COUNTY, United Kingdom
Patent: 15
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 7
Neurim Pharmaceuticals Ltd.
Israel
Patent: 3
The Schepens Eye Research Institute, Inc.
Massachusetts, United States
Patent: 2
Kunming Second People's Hospital
undefined undefined
Patent: 2
Bioprojet Pharma SARL
France
Patent: 1
Universitas Diponegoro
Jawa Tengah, Indonesia
Patent: 1
Nanjing Zhijingling Educational Technology Co. Ltd.
Zhejiang Sheng, China
Patent: 1
Bar-Ilan University
Israel
Patent: 1
Hangzhou Tonghui Technology Co., Ltd.
Zhejiang Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 43 patents in last 5 years, we discover 13 new entrants. Heptares Therapeutics Ltd., Neurim Pharmaceuticals Ltd., The Schepens Eye Research Institute, Inc. are the most active new entrants in this area.
Heptares Therapeutics Ltd.
HERTFORD COUNTY, United Kingdom
Patent: 15
Neurim Pharmaceuticals Ltd.
Israel
Patent: 3
The Schepens Eye Research Institute, Inc.
Massachusetts, United States
Patent: 2
Kunming Second People's Hospital
undefined undefined
Patent: 2
Bioprojet Pharma SARL
France
Patent: 1
Universitas Diponegoro
Jawa Tengah, Indonesia
Patent: 1
Nanjing Zhijingling Educational Technology Co. Ltd.
Zhejiang Sheng, China
Patent: 1
Bar-Ilan University
Israel
Patent: 1
Hangzhou Tonghui Technology Co., Ltd.
Zhejiang Sheng, China
Patent: 1
Astrogen Co., Ltd.
South Korea
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 25 patents, we discovered top 7 universities and scientific research institutions by total patent application. Council of Scientific & Industrial Research, Korea Advanced Institute of Science & Technology, Drexel University are dominant in this area. They take 56.00% of the total patent filing.
Council of Scientific & Industrial Research
Delhi, India
Patent: 7
Korea Advanced Institute of Science & Technology
South Korea
Patent: 4
Drexel University
Pennsylvania, United States
Patent: 3
Beihang University
Beijing Shi, China
Patent: 1
Bar-Ilan University
Israel
Patent: 1
Universitas Diponegoro
Jawa Tengah, Indonesia
Patent: 1
Tianjin University
Tianjin Shi, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: